EU ingredient rules · 1 min read
5-Bromo-5-Nitro-1,3-Dioxane in cosmetics: EU rules
Quick answer: 5-Bromo-5-Nitro-1,3-Dioxane is one of the preservatives the EU allows in cosmetics (Annex V, entry 20), at up to 0.1% in the ready-to-use product. CosIng lists its functions as preservative.
Key facts
| INCI name | 5-BROMO-5-NITRO-1,3-DIOXANE |
|---|---|
| CAS number | 30007-47-7 |
| EC number | 250-001-7 |
| EU status | Permitted preservative (Annex V, entry 20) |
| Functions (CosIng) | Preservative |
What it does in a product
- Preservative: Protects the product itself from bacteria and mold, which is a big part of why an opened product stays usable.
Annex V: permitted preservatives, entry 20
Annex V is the list of preservatives allowed in cosmetic products in the EU, each with a maximum concentration. A substance used mainly to stop microorganisms growing in a product must be on this list.
Maximum concentration in the ready-to-use product: 0.1%
Product type or body part:
Rinse-off products
Other conditions:
Avoid formation of nitrosamines
Most recent legal act listed by CosIng for this entry: Regulation (EC) 2009/1223.
Scientific Committee on Consumer Safety (SCCS) opinions:
- Opinion on The Determination of certain Formaldehyde Releasers in Cosmetic Products
- SCIENTIFIC ADVICE ON the threshold for the warning ‘contains formaldehyde’ in Annex V, preamble point 2 for formaldehyde-releasing substances
Why it matters for shelf life
Preservatives are a large part of why an opened product stays safe to use until the end of its period after opening (the open-jar symbol). Once that period has passed, or if water, fingers or heat have got into the product, the preservative system may no longer keep microbes in check.
Not sure how to read a label? What an INCI name is · How ingredient lists work
Source
European Commission, CosIng (Cosmetic Ingredients database), entries for 5-BROMO-5-NITRO-1,3-DIOXANE and Annex V/20, retrieved 2026-10-11. CosIng is provided for information only and has no legal value; the legally binding text is Regulation (EC) No 1223/2009 and its amendments as published in the Official Journal of the European Union. Rules outside the EU, for example in the US, can differ. This page is not legal or medical advice.